Your browser doesn't support javascript.
loading
A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing Sarcoma.
Guenther, Lillian M; Dharia, Neekesh V; Ross, Linda; Conway, Amy; Robichaud, Amanda L; Catlett, Jerrel L; Wechsler, Caroline S; Frank, Elizabeth S; Goodale, Amy; Church, Alanna J; Tseng, Yuen-Yi; Guha, Rajarshi; McKnight, Crystal G; Janeway, Katherine A; Boehm, Jesse S; Mora, Jaume; Davis, Mindy I; Alexe, Gabriela; Piccioni, Federica; Stegmaier, Kimberly.
Affiliation
  • Guenther LM; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.
  • Dharia NV; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.
  • Ross L; Broad Institute, Cambridge, Massachusetts.
  • Conway A; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.
  • Robichaud AL; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.
  • Catlett JL; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.
  • Wechsler CS; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.
  • Frank ES; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.
  • Goodale A; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.
  • Church AJ; Broad Institute, Cambridge, Massachusetts.
  • Tseng YY; Broad Institute, Cambridge, Massachusetts.
  • Guha R; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts.
  • McKnight CG; Broad Institute, Cambridge, Massachusetts.
  • Janeway KA; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, NIH, Rockville, Maryland.
  • Boehm JS; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, NIH, Rockville, Maryland.
  • Mora J; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.
  • Davis MI; Broad Institute, Cambridge, Massachusetts.
  • Alexe G; Department of Pediatric Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Piccioni F; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, NIH, Rockville, Maryland.
  • Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.
Clin Cancer Res ; 25(4): 1343-1357, 2019 02 15.
Article in En | MEDLINE | ID: mdl-30397176
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma, Ewing / Receptor, IGF Type 1 / Cyclin-Dependent Kinase 4 / Cyclin-Dependent Kinase 6 Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2019 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma, Ewing / Receptor, IGF Type 1 / Cyclin-Dependent Kinase 4 / Cyclin-Dependent Kinase 6 Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2019 Document type: Article Country of publication: United States